Status:
COMPLETED
Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan
Lead Sponsor:
Istanbul University
Conditions:
Neuropathy Autonomic
Cardiac Autonomic Neuropathy
Eligibility:
All Genders
18+ years
Brief Summary
Neuropathy is a frequently observed complication occurring in 60-70% of diabetic patients throughout their lives. In addition, neuropathy is a severe disease that progresses insidiously; its diagnosis...
Eligibility Criteria
Inclusion
- The ability to give informed consent
- Male or female persons \>18 years of age with a diagnosis of type 2 DM (WHO criteria)
Exclusion
- \<18 years of age
- Participants with type 1 diabetes
- Ongoing cancer treatment or other concurrent illness that will make the patient unable to attend the study at the discretion of the investigator
- Pregnant or breastfeeding participants
- Participants with atrial fibrillation, atrial flutter, or pacemakers will not be subjected to cardiac autonomic neuropathy measurements.
- Participants with toe or foot amputations or foot ulcer
- vitamin B12 deficiency and other causes of peripheral neuropathy.
Key Trial Info
Start Date :
July 15 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2015
Estimated Enrollment :
437 Patients enrolled
Trial Details
Trial ID
NCT05299918
Start Date
July 15 2014
End Date
July 15 2015
Last Update
April 6 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.